announced today that the Company will attend two major health conferences and present posters on its Software as a Medical Device (SaMD) eyonis® LCS, for Lung Cancer Screening. The eyonis® LCS ...

Poster #13190: AI-Assisted Lung Cancer Screening: Results from REALITY, a Pivotal Validation Study of an AI/ML-Based Software Poster Session: B110 - The road to Early Detection: Advancing Lung ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.